GNRH1 and polycystic ovary syndrome: Additionally, growing evidence supports the involvement of GnRH-regulatory neurotransmitters and neuropeptides in the pathogenesis of PCOS (28–30); however, lacks electrophysiological analysis for the letrozole-induced PCOS model.